Vaccine Therapy in Treating Patients With Metastatic Melanoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1999
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Interleukin-2 may stimulate a person\'s white blood cells to kill tumor cells. PURPOSE: Randomized phase II trial to study the effectiveness of vaccine therapy with and without interleukin-2 in treating patients who have metastatic melanoma that has not responded to previous treatment.
Epistemonikos ID: e21754a3ca9944f1c3cd5d43de24a61eed92ca4c
First added on: Mar 22, 2020